Evidence map›Paper›PMID 36681537›Full record

ArticleEuropean urology2023

Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605].

Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, Menelaos Pavlou, Rumana Omar, Sola Adeleke, Francesco Giganti, Chris Brew-Graves, Norman R Williams, Jack Grierson and 22 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in European urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Taimur T ShahImperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery and Interventional Sciences, University College London, London, UK. Electronic address: t.shah@imperial.ac.uk.
Abi KanthabalanDivision of Surgery and Interventional Sciences, University College London, London, UK.
Marjorie OtienoDivision of Surgery and Interventional Sciences, University College London, London, UK.
Menelaos PavlouDepartment of Statistical Science, University College London, London, UK.
Rumana OmarDepartment of Statistical Science, University College London, London, UK.
Sola AdelekeDivision of Medicine, Faculty of Medicine, University College London, London, UK; Department of Oncology, King's College London, London, UK; Department of Oncology, Maidstone and Tunbridge Wells Hospital, Maidstone, UK; School of Cancer & Pharmaceutical Sciences, King's College London, Queen Square, London WC1N 3BG, UK; High Dimensional Neurology, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK.
Francesco GigantiDivision of Surgery and Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
Chris Brew-GravesDivision of Medicine, Faculty of Medicine, University College London, London, UK.
Norman R WilliamsDivision of Surgery and Interventional Sciences, University College London, London, UK.
Jack GriersonDivision of Surgery and Interventional Sciences, University College London, London, UK.
Haroon MiahDivision of Surgery and Interventional Sciences, University College London, London, UK.
Amr EmaraDepartment of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; Urology Department, Ain Shams University Hospitals, Cairo, Egypt.
Athar HaroonDepartment of Nuclear Medicine, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
Arash LatifoltojarDivision of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK.
Harbir SidhuDivision of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
Joey ClementeDivision of Surgery and Interventional Sciences, University College London, London, UK.
Alex FreemanDepartment of Histopathology, University College London Hospital NHS Foundation Trust, London, UK.
Clement OrczykDivision of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
Ashok NikapotaSussex Cancer Centre. Royal Sussex County Hospital, Brighton, UK.
Tim DudderidgeDepartment of Urology, University Hospital Southampton NHS Trust, Southampton, UK.
Richard G HindleyDepartment of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK.
Jaspal VirdiDepartment of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK.
Manit AryaImperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Heather PayneDepartment of Oncology, University College London and University College London Hospital NHS Foundation Trust, London, UK.
Anita MitraDepartment of Oncology, University College London and University College London Hospital NHS Foundation Trust, London, UK.
Jamshed BomanjiInstitute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.
Mathias WinklerImperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Gail HoranDepartment of Oncology, Queen Elizabeth Hospital, Kings Lynn, UK.
Caroline M MooreDivision of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
Mark EmbertonDivision of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
Shonit PunwaniDivision of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK.
Hashim U AhmedImperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.